Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Revealing transparency gaps in publicly available COVID-19 datasets used for medical artificial intelligence development-a systematic review.
Alderman JE, Charalambides M, Sachdeva G, Laws E, Palmer J, Lee E, Menon V, Malik Q, Vadera S, Calvert M, Ghassemi M, McCradden MD, Ordish J, Mateen B, Summers C, Gath J, Matin RN, Denniston AK, Liu X. Alderman JE, et al. Among authors: matin rn. Lancet Digit Health. 2024 Nov;6(11):e827-e847. doi: 10.1016/S2589-7500(24)00146-8. Lancet Digit Health. 2024. PMID: 39455195 Free article.
Diversity, inclusivity and traceability of mammography datasets used in development of Artificial Intelligence technologies: a systematic review.
Laws E, Palmer J, Alderman J, Sharma O, Ngai V, Salisbury T, Hussain G, Ahmed S, Sachdeva G, Vadera S, Mateen B, Matin R, Kuku S, Calvert M, Gath J, Treanor D, McCradden M, Mackintosh M, Gichoya J, Trivedi H, Denniston AK, Liu X. Laws E, et al. Clin Imaging. 2024 Nov 26;118:110369. doi: 10.1016/j.clinimag.2024.110369. Online ahead of print. Clin Imaging. 2024. PMID: 39616879 Free article. Review.
Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendations.
Alderman JE, Palmer J, Laws E, McCradden MD, Ordish J, Ghassemi M, Pfohl SR, Rostamzadeh N, Cole-Lewis H, Glocker B, Calvert M, Pollard TJ, Gill J, Gath J, Adebajo A, Beng J, Leung CH, Kuku S, Farmer LA, Matin RN, Mateen BA, McKay F, Heller K, Karthikesalingam A, Treanor D, Mackintosh M, Oakden-Rayner L, Pearson R, Manrai AK, Myles P, Kumuthini J, Kapacee Z, Sebire NJ, Nazer LH, Seah J, Akbari A, Berman L, Gichoya JW, Righetto L, Samuel D, Wasswa W, Charalambides M, Arora A, Pujari S, Summers C, Sapey E, Wilkinson S, Thakker V, Denniston A, Liu X. Alderman JE, et al. Among authors: matin rn. Lancet Digit Health. 2024 Dec 12:S2589-7500(24)00224-3. doi: 10.1016/S2589-7500(24)00224-3. Online ahead of print. Lancet Digit Health. 2024. PMID: 39701919 Free article. Review.
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
Dayimu A, Gupta A, Matin RN, Nobes J, Board R, Payne M, Rao A, Fusi A, Danson S, Eccles B, Carser J, Brown CO, Steven N, Bhattacharyya M, Brown E, Gonzalez M, Highley M, Pickering L, Kumar S, Waterston A, Burghel G, Demain L, Baker E, Wulff J, Qian W, Twelves S, Middleton M, Corrie P. Dayimu A, et al. Among authors: matin rn. Eur J Cancer. 2024 Jan;196:113455. doi: 10.1016/j.ejca.2023.113455. Epub 2023 Nov 24. Eur J Cancer. 2024. PMID: 38029480 Free article. Clinical Trial.
109 results